Company ProfilePremium

Synergia Energy Ltd (formerly Oilex Ltd)

Company Profile Analysis

Ticker: SYN.L

ESOMAR 23 Corporate BadgeISO Certifications Badge
Synergia Energy Ltd - Company showcase

Year Founded & Workforce

1997

29 Employees

Synergia Energy Ltd logo

Synergia Energy Ltd Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Synergia Energy Ltd Overview

Synergia Energy is a Perth-headquartered, AIM-quoted nano-cap upstream oil and gas company whose economic value now rests almost entirely on one asset: a 50% participating interest in the onshore Cambay Production Sharing Contract (PSC) in Gujarat, India. It is joint operator there alongside Antelopus Selan Energy Ltd, which funds and leads a US$20 million work programme under a 2024 farm-out. Formerly Oilex Ltd, the company spent two decades as a frontier and junior explorer across India, the Timor Sea, Indonesia, Australia and the UK. It rebranded in 2022 around "responsible gas" and carbon capture and storage (CCS), and in 2025–26 it attempted to exit Cambay entirely for up to US$14 million. That sale collapsed in February 2026. In June 2026 Synergia announced it would relinquish its UK Camelot CCS licence. What remains is a cash-constrained, going-concern-qualified company with modest oil production, a large stated Eocene gas resource, a nascent Cambay CCS concept, and dependence on its largest shareholder for working capital.


What the company does

Synergia Energy explores for, appraises, develops, produces and sells hydrocarbons, mainly natural gas and associated oil and condensate. It also develops CCS projects. Its business description, as reproduced by Morningstar and AJ Bell, has three parts:

  • a focus on "responsible" gas production;

  • identifying natural gas assets with development potential in gas-producing basins;

  • an aim to contribute to CO2 emission reduction through CCS.

Data vendors note that the majority of revenue comes from India.

In practice, as of October 2026, the operating business consists of:

  1. Cambay PSC (onshore Gujarat, India) — 50% participating interest, joint operator. Oil production comes mainly from worked-over legacy wells (C-64, C-74, C-08). There are small gas volumes from the horizontal multi-stage fracked well C-77H. A new Oligocene gas discovery test was made at C-78, and the Eocene-targeted C-79 well is planned to spud in late November 2026.

  2. Cambay CCS Scheme (India) — 100% interest, operator. This is a pre-FID concept to inject CO2 into the thick Olpad Formation beneath the Cambay field. The British Geological Survey joined the consortium in October 2024. A pilot was proposed for calendar 2026, subject to Indian regulatory engagement.

  3. Medway Hub Camelot CCS Project (UK Southern North Sea, licence CS019) — 50%, operator. Being relinquished. On 16 June 2026 the company announced it would give up its interest, citing legacy well-integrity uncertainties.

Business and revenue model

Revenue model componentShare of revenueCommentary
Product sales — crude oil and condensate (India)Majority (exact split not disclosed)Sold within India under PSC terms. Synergia's net share fell after the 2024 farm-out.
Product sales — natural gas (India)MinorityVery small volumes, e.g., 39 Mcf/d gross from C-77H in April 2026
Services, subscriptions, licensing0%Not applicable
CCS revenue0%Pre-revenue. No storage contracts.
One-off gains on asset transactionsNot revenue, but dominant P&L driverA$8.4m gain on the Cambay farm-out in FY2025 drove the only profitable year in the period

Revenue is small. Gas and oil sales were A$292,179 in FY2025, versus A$638,457 in FY2024, and A$116,469 in H1 FY2026. Value creation has historically come from asset transactions (farm-outs, sales), not operating cash flow.

Value-chain position, customers and end-markets

Synergia sits purely in the upstream segment: exploration, appraisal, development and production. It has no midstream, refining or marketing assets. Customers are Indian domestic offtakers of crude and gas from the Cambay field. Named counterparties are not publicly disclosed in the sources reviewed. Its end-market is the Indian domestic energy market, which is structurally short of oil and gas and import-dependent. On the CCS side, the targeted end-market was industrial emitters around the UK Thames/Medway area (now abandoned) and, prospectively, Gujarat industrial emitters.

Independent characterisation

Synergia is best understood as a single-asset, sub-scale, financially fragile junior whose equity is effectively a call option on the Cambay Eocene tight-gas resource. The company itself cites a P50 gas figure of around 206 Bcf, as reported by Kalkine in July 2026. That figure is the company's own claim, and its classification (reserve versus contingent resource) should be checked in the competent-person report.

The company has repeatedly re-framed its strategy:

  • frontier explorer (Oilex, 2000s–2010s);

  • "Super Basins" junior (late 2010s);

  • "responsible gas plus CCS double play" (2022–2025);

  • "exit and return capital" (2025);

  • back to "focused Cambay developer plus E&P opportunities" (June 2026).

Each pivot has followed a funding or transaction setback. The 2024 Selan farm-out is the company's most consequential achievement in a decade. It transferred most of the capital burden for Cambay to a better-funded partner.

Strategy

Evolution of stated strategy

PeriodStated strategy theme (paraphrased)Source
Late 2010s (Oilex)Focus on "Super Basins" open to juniors, with supportive regulators, rich open-file data and low-cost entry pointsSharecast legacy profile
2022–2024"Responsible gas" production plus CCS: develop Cambay gas and become a CO2-reduction contributor via CCS (Medway Hub Camelot; Cambay CCS)Company description (Morningstar / AJ Bell)
FY2025 Annual Report (Oct 2025)Complete the Cambay sale, return a substantial part of the proceeds to shareholders, then reset strategy toward CCS development and new value-accretive opportunitiesFY2025 Annual Report RNS; Alliance News
H1 FY2026 report (Mar 2026)Strategic review of Cambay after the failed sale; seek a new Camelot partner; engage Indian regulators on the Cambay CCS pilotInterim Report, 26 Mar 2026
16 Jun 2026Relinquish Camelot; refocus on developing Cambay and assessing additional E&P opportunities; retain CCS exposure via Cambay CCSRNS, 16 Jun 2026

Initiatives in the last 24 months (Oct 2024 – Oct 2026)

InitiativeStatus (Oct 2026)
Selan-funded US$20m Cambay work programme (workovers; new vertical wells C-78, C-79; horizontal frac well)Ongoing. C-78 tested gas (Jan 2026). C-79 spud late Nov 2026 (est.).
C-77H artificial liftImplemented (2024–25); low gas rate (39 Mcf/d, Apr 2026)
Legacy-well workover programme (C-64, C-74, C-08)Completed; oil production lifted to roughly 150–195 bopd gross at peaks
Sale of remaining 50% Cambay to Selan (up to US$14m)Failed (Feb 2026); US$0.5m retained
Planned AIM cancellation (tied to sale)Rejected by shareholders / moot (Dec 2025)
Capital return to shareholdersContingent on sale; no longer applicable
Camelot CCS phasing (two phases, first injection 2030/31)Abandoned with relinquishment (Jun 2026)
Cambay CCS pilot (with BGS)Pre-pilot; regulatory engagement continuing
Cost reduction / board slimmingMark Bolton departure; management has stressed cost discipline
Working-capital facilityUS$0.7m Republic loan (Apr 2026)

Medium-term targets / guidance

The company has no quantified medium-term financial guidance: no production, revenue, capex or margin targets. The only dated operational guidance is the C-79 spud, estimated for late November 2026.

Products & Services

Synergia sells commodities, not branded products. Its "portfolio" is a set of assets and projects, catalogued below.

Cambay PSC — Onshore Gujarat, India (Synergia 50% PI, joint operator; partner Antelopus Selan Energy Ltd 50%, lead operator)

AttributeDetail
DescriptionMature onshore oil and gas field in the Cambay Basin, with shallow oil zones and a deep, tight Eocene gas/condensate reservoir
Key reservoirsEocene (tight gas, requires hydraulic fracturing); Oligocene (OS-II zone gas tested at C-78); shallower oil zones
Resource claimCompany cites P50 Eocene gas of about 206 Bcf. Classification should be checked in the CPR.
Producing wells (2025–26)C-64 and C-74 (oil; worked over Oct 2025 with sucker rod pumps); C-08 (oil; worked over May 2026, about 30 bopd); C-77H (gas, horizontal multi-stage fracked well; artificial lift installed; 39 Mcf/d in Apr 2026); C-19z (existing Eocene producer near the planned C-79)
Recent production (gross)About 40 bopd stabilised (Jan 2026); about 195 bopd (early Mar 2026); 148 bopd (Apr 2026); C-08 adds about 30 bopd (Jun 2026). Production is volatile and from a small well count.
Recent drillingC-78: drilled, cased, perforated over 5 m in the Oligocene OS-II zone; gas shown during clean-up; under pressure observation (Jan 2026)
Planned drillingC-79: Eocene primary target near C-19z; vertical/deviated well with hydraulic fracking; DEEP Industries rig; spud estimated late Nov 2026
Farm-out economicsSelan funds a US$20m work programme: workovers of C-70 and C-63, two vertical wells, and one multi-stage fracked horizontal well. Synergia received a US$2.5m lump sum for past costs.
Target customerIndian domestic crude and gas buyers (not named)
PricingIndian domestic pricing under PSC terms (specifics not disclosed)

Cambay CCS Scheme — India (Synergia 100%, operator)

AttributeDetail
ConceptCapture CO2 from regional emitters, pipeline it to a CCS hub on the Cambay field, and inject it into the Olpad Formation for permanent storage
Storage formationOlpad Formation, up to about 1 km thick in the Cambay Basin. Company believes it could form a national-scale CO2 storage resource.
PartnersBritish Geological Survey joined the consortium (Oct 2024); other consortium members not fully disclosed
StagePre-pilot. Pilot proposed for calendar 2026, subject to regulatory engagement. No pilot start announced at dossier date.
Pricing / revenue modelNot disclosed (likely storage tariff or carbon-credit model if developed)

Medway Hub Camelot CCS Project — UK Southern North Sea (licence CS019; Synergia 50%, operator; partner Harbour Energy 50%) — being relinquished

AttributeDetail
ConceptStore CO2 from Thames/Medway industrial emitters in the depleted Camelot gas field area
PhasingSplit into two phases to reduce risk and cost; initial injection targeted 2030/2031 (FY2025 Annual Report)
Key issueLegacy wells drilled about 50 years ago and abandoned with open-hole sections in the Leman Sandstone and Zechstein. There is uncertainty over abandonment records and 1970s logs.
RegulatoryLegacy well integrity risk assessment submitted to NSTA in Nov 2025; reviewed at an NSTA workshop on 9 Jun 2026; work-programme delay previously agreed with NSTA
Partner statusHarbour Energy (successor to Wintershall Dea) gave notice of withdrawal on 28 Nov 2024. No replacement partner was found.
Outcome16 Jun 2026: Synergia announced relinquishment. Harbour reportedly also expected to relinquish.

Historical / divested portfolio (for completeness)

AssetCountryStatusNotes
Cooper-Eromanga Basin interestsAustraliaDivested to Armour Energy (2022)Cited as a reason for ASX delisting
Bhandut field †IndiaLegacy interestHistorical Gujarat asset alongside GSPC
JPDA 06-103 †Timor SeaTerminated (mid-2010s)Frontier offshore; regulatory dispute
West Kampar PSC †Indonesia—Historical
Canning Basin permits †AustraliaExitedHistorical
UK exploration interests †UKNot currentPre-CCS UK activity

Financial Narrative

Sources: FY2022 and FY2023 figures from FY2023 results (Alliance News, 21 Sep 2023) and Fintel's quarterly data. FY2024 and FY2025 from the FY2025 Annual Report summary RNS (7 Oct 2025) and Alliance News (Oct 2025). Half-year data from interim reports (13 Mar 2025, 26 Mar 2026) and Google Finance (Dec 2023). All figures in A$ millions unless stated. Figures computed from these inputs are labelled "derived".

Income statement

Revenue CAGR FY2022–FY2025 (derived): about +27% a year, from A$0.141m to A$0.292m. This figure is not meaningful. It spans a peak in FY2023 and a structural halving of Synergia's working interest in FY2025.

Commentary:

FY2022–FY2023: The company carried 100% of Cambay costs while restarting and stimulating wells. Revenue rose about ninefold, but cost of sales more than tripled, so losses widened to A$5.4m before tax. Management nonetheless described the outlook as very positive at the time.

FY2024: The net loss narrowed to A$2.8m as farm-out negotiations progressed.

FY2025: The A$8.4m farm-out gain produced a reported net profit of A$5.0m. Underlying operations remained loss-making.

Half-year income statement: notes and sources

Sources: Google Finance (Dec 2023 half); interim report 13 Mar 2025; interim report 26 Mar 2026 and Alliance News coverage. The H1 FY2025 pre-tax figure (A$6.3m, Alliance News) and net figure (A$10.59m, interim report as summarised by ticker.app) are reported as given and are not fully reconcilable from public summaries.

Balance sheet

Commentary:

  • At 30 June 2025 the company reported no unsecured borrowings. All prior debt had been extinguished through repayments and equity conversions.

  • Cash fell from A$1.21m (June 2025) to A$0.81m (December 2025).

  • In April 2026 the company re-levered with the US$0.7m Republic facility.

  • Net assets of about A$18m are dominated by the carrying value of Cambay. That value was underpinned by the US$14m sale price until February 2026, and could be impaired in FY2026 now that the sale has failed.

  • The gap between book equity (about A$18m) and market capitalisation (about £1.6m, roughly A$3m) shows that the market heavily discounts the realisability of Cambay value.

  • Working capital, goodwill and the detailed debt split were not verifiable. The company has no goodwill of note.

Cash flow

No dividends have been paid and there is no buyback programme.

Pattern: Operating cash flow has been consistently negative. The company is funded by equity placements (e.g., £750,000 in Feb 2025; issues in Nov 2024), convertible loans (£0.65m in Feb 2023), asset-transaction cash (US$2.5m past-cost lump sum from Selan in 2024; US$0.5m sale deposit in Aug 2025) and shareholder loans (US$0.7m in Apr 2026).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment / Region Details

Segment / RegionContentsProductsRevenueOperating result

India — Cambay PSC

50% PI (joint operator) in Cambay field, Gujarat

Crude oil, condensate, natural gas

100% of group sales revenue (company reports revenue only from India)

—

India — Cambay CCS

100% concept-stage CO2 storage scheme (Olpad Formation)

None (pre-revenue)

0

Pre-revenue costs; not separately disclosed

UK — Camelot CCS (CS019)

50% operated carbon storage licence; being relinquished

—0

Licence and study costs; not separately disclosed

Corporate

Perth head office, listing costs

—0

Corporate overhead

“—” = not publicly disclosed.

Revenue by Segment and Segment Margins & Growth (%)

SegmentFY2021FY2022FY2023FY2024FY2025

India oil and gas sales (AUD Mn)

—0.1411.300.6380.292

UK CCS revenue (AUD Mn)

00000

India % of total revenue

—100100100100

YoY growth India sales (%)

——822-51-54

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue — oil and gas sales (AUD Mn)

—0.1411.300.6380.292

Cost of sales (AUD Mn)

—0.7542.6——

Gross profit (AUD Mn, derived)

—-0.613-1.30——

Gain on Cambay farm-out (AUD Mn)

————8.4

Pre-tax profit (loss) (AUD Mn)

—-2.1-5.4——

Net profit (loss) after tax (AUD Mn)

——-5.38-2.85.0

Dividends per share (AUD)

00000

Gross margin (%, derived)

—-435-100——

Net margin (%, derived)

——-414-4391,712

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement

MetricH1FY2024H1FY2025H1FY2026

Revenue (AUD Mn)

0.1770.1560.116

Pre-tax profit (loss) (AUD Mn)

—6.3-0.575

Net profit (loss) (AUD Mn)

-1.0310.59-0.575

EBITDA (AUD Mn)

-1.12——

Operating expense (AUD Mn)

0.929——

Balance Sheet

MetricFY2024FY2025

Cash at bank (AUD Mn)

1.071.21

Total borrowings (AUD Mn)

—0

Net assets / equity (AUD Mn)

9.9618.95

Balance Sheet and Share Count (billions)

MetricDec2023Dec2025

Cash and short-term investments (AUD Mn)

1.790.81

Total assets (AUD Mn)

19.79—

Total liabilities (AUD Mn)

8.26—

Total equity (AUD Mn)

11.5317.96

Shares outstanding (billions)

10.5015.6

Cash Flow

MetricH1FY2024

Cash from operations (AUD Mn)

-0.677

Cash from investing (AUD Mn)

-0.288

Cash from financing (AUD Mn)

1.39

Free cash flow (AUD Mn)

-1.15

Net change in cash (AUD Mn)

0.425

Financial Analysis

RatioValueBasis / Source

ROE

-9.59%

MarketInOut (TTM, Jun 2026)

ROA

-7.68%

MarketInOut (TTM, Jun 2026)

ROIC

-14.07%

MarketInOut (TTM, Jun 2026)

Debt / equity

0.00 at Jun 2025; small positive after Apr 2026 loan

FY2025 AR; RNS 7 Apr 2026

Net debt / EBITDA

Not meaningful (negative EBITDA)

—

Asset turnover

About 0.015x (FY2025 revenue / net assets, derived)

Derived

Cash conversion cycle

Not disclosed / not meaningful

—

Altman Z-score

-9 (distress zone)

MarketInOut

Piotroski F-score

4/9

MarketInOut

Revenue by Region

RegionFY2021FY2022FY2023FY2024FY2025

India revenue (AUD Mn)

—0.1411.300.6380.292

United Kingdom revenue (AUD Mn)

00000

Australia revenue (AUD Mn)

—0000

Change by Period

PeriodChangeSource / Date

1 month

-16.7%

MarketInOut, as of 17 Jun 2026

6 months

+26.6%

MarketInOut, as of 17 Jun 2026

1 year

-49.0%

MarketInOut, as of 17 Jun 2026

1 year (earlier snapshot)

-35%

Alliance News, Mar 2026

3 years

-86%

Simply Wall St (earlier snapshot, date not specified)

5 years

-77%

Simply Wall St (earlier snapshot, date not specified)

Price point

Value

Date

Recent quote

About 0.0105p (market cap about £1.64m)

lse.co.uk (2026 snapshot)

Feb 2026

About 0.01p

Fintel, 9 Feb 2026

Mar 2026

0.013p

Alliance News, 26 Mar 2026

Oct 2025

0.020p

Alliance News, 7 Oct 2025

2023

0.12–0.13p

Alliance News / Google Finance

Dec 2022 (final ASX)

A$0.001

InvestSMART

Share Count (billions)

MetricFY2023FY2024FY2025FY2026

Representative share price (GBp)

0.12—0.020.01

Shares outstanding (billions)

—10.50—15.6

Valuation Multiples

MultipleSynergiaComment

P/E

n/m

Loss-making excluding one-offs

EV/EBITDA

-1.19x

MarketInOut (negative EBITDA; not meaningful)

EV/Sales

8.66x

MarketInOut

P/B

About 0.15–0.2x (derived: about A$3m market cap vs A$17.96m net assets at Dec 2025)

Deep discount to book

Peer comparison

Not compiled

—

Capital Markets

ItemDetail

Analyst consensus

No major broker coverage (Market Index). Simply Wall St cites 2 covering analysts. Fintel shows a 0.95 GBX one-year "target", which is roughly 90 times the current price, appears stale or erroneous, and should be disregarded. SP Angel has published flash notes (e.g., Jul 2025, "Proposed $14m Cambay sale unlocks value").

Dividend history / policy

No dividends ever paid. A planned capital return contingent on the Cambay sale lapsed.

Credit ratings

None (Moody's, S&P, Fitch: not rated)

Debt maturity profile

US$0.7m Republic facility. Tranche 1 of US$350k available from 20 Apr 2026, repayable within 12 months of first drawdown (by about Apr 2027 if drawn at availability). Tranche 2 of US$350k from no earlier than 1 Sep 2026 by agreement. 7.5% interest; unsecured. Drawdown status not disclosed.

Historical financing pattern

2015 placements (A$0.041); 2018 (0.19p); 2020 (A$0.00266); 2023 convertible (0.08p); Nov 2024 equity issue and option exercise; Feb 2025 £750k raise

Analyst Conclusions

Management guidance

No financial guidance has been given. Operational guidance:

  • C-79 Eocene fracked well to spud in late November 2026.

  • Continued workovers to sustain oil output.

  • Strategic review of Cambay options, including potential sale or partnership.

  • Cambay CCS regulatory engagement.

  • Assessment of new E&P opportunities.

Consensus

None is available.

Bull case

  1. Asymmetric resource leverage: A market cap of about £1.6m against a company-cited P50 gas resource of about 206 Bcf and a recent arm's-length price benchmark of up to US$14m for the same 50% interest. If C-79 flows commercially, the gap could close sharply.

  2. Carried exposure: Selan's US$20m programme funds the key wells (C-78, C-79, horizontal frac), so Synergia gets drilling upside without proportional capex.

  3. Simplified story, lower liabilities: Exiting Camelot removes UK legacy-well exposure and non-core spend. Workovers have demonstrably lifted oil output to roughly 150–195 bopd gross.

Bear case

  1. Funding cliff: Cash of A$0.81m (Dec 2025), a going-concern warning, and a 12-month related-party loan make a dilutive raise likely across about 15.6 billion shares.

  2. Monetisation credibility damaged: The only buyer, which is also the operator, could not complete the purchase. A US$14m valuation is now unproven, and a FY2026 impairment against A$18m book value is possible.

  3. Technical track record: Prior fracked Eocene wells (e.g., C-77H at 39 Mcf/d) underwhelmed. C-79 may repeat this, and revenue is in steady decline (FY2023 A$1.30m → H1 FY2026 A$0.116m).

Key catalysts and monitorables (next 12 months)

TimingCatalyst / monitorable
Oct–Dec 2026FY2026 Annual Report: impairment, going-concern wording, cash at 30 Jun 2026
27 Nov 2026 (vendor calendar)AGM: resolutions on capital authorities and board
Late Nov 2026 onwardC-79 spud, frac and flow-test results
OngoingC-78 Oligocene gas monetisation plan
OngoingMonthly production updates (target: sustain over 150 bopd gross)
H1 2027Drawdown and repayment of the Republic loan; any equity raise
Any timeNew Cambay sale or partnership; Selan relationship developments
Any timeConfirmation of Camelot relinquishment completion and any residual obligations
Mar 2027H1 FY2027 interim report

Analyst verdict

Synergia Energy, formerly Oilex, is a 29-year-old junior that has never become self-funding. Over two decades it cycled through frontier exploration, a "Super Basins" strategy, a gas-plus-CCS "double play" and a planned exit. The only consistent constant is the Cambay field in Gujarat. That asset is real and has a cited resource of about 206 Bcf P50. Its development is carried by Antelopus Selan through a US$20m work programme, and in July 2025 an arm's-length counterparty agreed to pay up to US$14m for Synergia's remaining 50%. Against a market capitalisation of roughly £1.6m, those facts describe a deeply discounted option.

The discount exists for documented reasons. The Selan sale collapsed in February 2026 when its buyer's controlling shareholder declined to proceed. The UK Camelot CCS project, the cornerstone of the 2022 rebrand, is being relinquished. Cash stood at A$0.81m at December 2025, and auditors flagged a material going-concern uncertainty. The company now depends on a US$0.7m loan from its largest shareholder. Underlying revenue has fallen for three consecutive periods, and reported profit in FY2025 came entirely from a non-recurring farm-out gain.

The investment case is now binary and near-dated. The C-79 Eocene fracked well, expected to spud in late November 2026, is the single most important event in the company's recent history. A commercial result would underpin the resource, restore negotiating leverage with Selan or a new buyer, and potentially justify a value several multiples of today's price. A disappointing result would probably force heavily dilutive financing or a distressed sale. Meanwhile the FY2026 accounts may bring an impairment and renewed going-concern scrutiny.

Verdict: Highly speculative and suitable only for risk capital. Fundamental value exists on paper, but realisation depends on the drill bit, partner behaviour and financing. None of these is in Synergia's sole control.


Sources consulted (primary and secondary)

  • Synergia Energy RNS announcements (via LSE/lse.co.uk, Investegate, Proactive, Stockopedia, ticker.app, dfcfw.com mirrors): 4 Aug 2025; 7 Oct 2025 (FY2025 Annual Report summary); 1 Dec 2025; 29 Dec 2025; 22 Jan 2026; 9 Feb 2026; 26 Mar 2026 (Interim Report); 7 Apr 2026; 5 May 2026; 16 Jun 2026; 1 Oct 2026; 13 Mar 2025 (Interim Report); 4 Feb 2025; 23 Oct 2024; 28 Nov 2024

  • ASX filings: Appendix 3B notices (2015–2020); delisting announcements (17–30 Nov 2022; 23 and 30 Dec 2022)

  • Alliance News (via AJ Bell / MoneyAM): FY2023 results (21 Sep 2023); FY2025 results (Oct 2025); H1 FY2026 results (Mar 2026); delisting coverage (Nov–Dec 2022)

  • Sharecast (convertible loan, 22 Feb 2023; company profile); energy-pedia (loan agreement, 7 Apr 2026); Kalkine (24 Jul 2026 analysis); Josh Thompson commentary (Apr 2026)

  • Data vendors: Market Index; MarketInOut; Morningstar; PitchBook; Google Finance; Fintel; Simply Wall St; Investing.com; MarketBeat; roic.ai; AJ Bell key dates; InvestSMART

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenureBackground / Prior rolesAge

Roland Wessel

CEO and Executive Director (MD/CEO)

Since 2021

Signs all 2024–2026 RNS as CEO; leads the CCS and Cambay strategy

69 (Investing.com)

Andrew Liam Darbyshire

CFO (Nov 2024) and Executive Director (4 Feb 2025)

Since Nov 2024

ICAEW Fellow; qualified 2011 at Garbutt & Elliott; Grant Thornton audit; built finance at Getech Group plc from 2014, on its board from 2018; MMath, University of York

42 at appointment (2024)

Ashish Khare

Executive Director & Head of India Assets

Since 2016

BE Chemical Engineering; leads Cambay operations

51 (Investing.com)

Jonathan (Joe) Salomon

Non-Executive Chairman

Board since 2015 (former Managing Director)

B App Sc (Geology), GAICD; long-serving MD of Oilex

66 (Investing.com)

Paul Haywood

Independent Non-Executive Director

Since 2017

Not detailed in sources reviewed

43 (Investing.com)

Peter Heinz Schwarz

Independent Non-Executive Director

Since 2019

Not detailed in sources reviewed

73 (Investing.com)

Stacey Britza

Non-Executive Director

Appointed May 2026 (RNS 12 May 2026)

Previously Synergia's Assistant (Company) Secretary

—

Luke Phillips

Company Secretary

Current per MarketBeat

——

“—” = not publicly disclosed.

Board & Management Changes

DateChangeContext
2021

Roland Wessel (CEO) and Colin Judd (CFO and director) appointed

Post-Salomon management era

23 Oct 2024 (eff. 4 Nov 2024)

Colin Judd steps down; Andrew Darbyshire appointed CFO

Finance transition

4 Feb 2025

Darbyshire joins board as Executive Director

Board strengthened ahead of the Cambay transaction

5 May 2026

Mark Bolton (NED, former CFO/Company Secretary) steps down

Cost/board refresh

12 May 2026

Stacey Britza appointed NED

Internal promotion

Earlier

Company secretaries have included Mark Bolton (2017), Jack Rosagro (2022), Anshu Raghuvanshi (from 2023 per Investing.com) and Luke Phillips

Turnover in the secretarial role

Governance Overview

FeatureAssessment

Board size

7 directors (after the May 2026 changes): 3 executive, 4 non-executive

Independence

2 directors described as independent NEDs (Haywood, Schwarz). The Chairman is a former MD and is not independent by usual standards. Britza is a former employee.

Chair / CEO separation

Yes (Salomon / Wessel)

Committee structure

Not detailed in sources reviewed; typical AIM audit and remuneration committees expected

Governance code

AIM Rule 26 requires adoption of a recognised code (likely QCA).

Major Shareholders

HolderStakeDate / Source

Republic Investment Management Pte Ltd (Singapore)

About 12.4%

Apr 2026 (related-party loan commentary)

Republic Investment Management Pte Ltd (historical)

16.07% (1,324,249,116 shares)

8 Jun 2022 (Market Index)

TH Investments Pte Ltd

1.95% (111,111,111 shares, historical)

Market Index (date of holding not specified)

Other TR-1 notifications

Filed 24 Jun 2025, 21 Jul 2025, 14 Mar 2025, 5 Dec 2024.

RNS headlines

Institutional ownership (top 10)

Not publicly disclosed in a compiled form. The register is predominantly UK retail via CREST depositary interests.

—

Insider ownership

Darbyshire held no shares at appointment (2024/25).

RNS

Competitive Landscape

Competitors by Segment

SegmentCompetitorRelevance

Cambay Basin onshore producers

Oil and Natural Gas Corporation (ONGC)

Dominant Cambay Basin operator

Cambay Basin onshore producers

Gujarat State Petroleum Corp (GSPC)

Former Cambay partner; state player

Cambay Basin onshore producers

Antelopus Selan Energy Ltd

JV partner, failed acquirer, and a consolidator of small Indian fields

Cambay Basin onshore producers

Hindustan Oil Exploration Company (HOEC)

Indian independent with Cambay and other onshore assets

Cambay Basin onshore producers

Sun Petrochemicals / Invenire Energy / other DSF-round awardees

Small-field operators

Indian upstream (broader)

Oil India Ltd; Vedanta (Cairn Oil & Gas)

Capital, rigs and services competition

Indian tight gas

ONGC (KG and Cambay tight programmes)

Technical and fracking service competition

AIM micro-cap E&P (capital competition)

Europa Oil & Gas; Union Jack Oil; Egdon/peers; Coro Energy; Pantheon Resources

Competing for UK retail E&P capital

UK CCS (historical)

Harbour Energy; Eni (Liverpool Bay); Perenco; Carbon Catalyst / other SNS licensees

Competitors for CO2 stores and emitter offtake (now moot)

Peer Comparison FY2025

MetricSynergia (FY2025)Antelopus Selan

Revenue

A$0.29m

—

Revenue growth

-54%—

Net margin

Distorted by one-off gain (+1,712%)

—

Cambay exposure

50% Cambay PSC

50% Cambay PSC

Recent Developments

--

Company Snapshot

$0.1M

Revenue

29

Employees

$2.3M

Market Cap

1997

Founded

Perth, Australia

Headquarters

SWOT Analysis

Strengths

  • Partner-carried development: Selan funds a US$20m Cambay work programme, which shields Synergia's balance sheet from most capex (farm-out effective Aug 2024).
  • Large stated gas resource: The company cites P50 Eocene gas of about 206 Bcf, which implies material in-ground value relative to a market cap of about £1.6m.
  • Production restored by workovers: Gross oil rose from about 40 bopd (Jan 2026) to about 195 bopd (early Mar 2026) and 148 bopd (Apr 2026), with C-08 adding about 30 bopd (Jun 2026).
  • Supportive anchor shareholder: Republic Investment Management (about 12–16% holder) supplied £0.33m of the 2023 convertible loan and the US$0.7m 2026 facility.
  • Clean balance sheet at FY2025: No unsecured borrowings at 30 June 2025, with all prior debt extinguished.
  • Retained non-refundable cash from the failed sale: The US$0.5m deposit (Aug 2025) was kept when the Selan deal collapsed.
  • Technical credibility in CCS: BGS joined the Cambay CCS consortium in October 2024.

Weaknesses

  • Going-concern qualification: Disclosed in both the FY2025 audit report and the H1 FY2026 interim report.
  • Minimal liquidity: Cash of A$0.81m at 31 December 2025, down from A$1.21m six months earlier.
  • Tiny, declining revenue: A$1.30m (FY2023) → A$0.638m (FY2024) → A$0.292m (FY2025) → A$0.116m (H1 FY2026).
  • Losses excluding one-offs: Every period without a transaction gain has been loss-making, e.g., an A$5.4m pre-tax loss in FY2023 and an A$0.575m loss in H1 FY2026.
  • Massive share count: About 15.6 billion shares at about 0.01p. Any equity funding is highly dilutive.
  • Thin, UK-retail-dominated liquidity: Bid–ask spreads of about 29–33% are quoted on lse.co.uk.
  • Limited board independence: Two independent NEDs out of seven; the Chair is a former MD.

Opportunities

  • C-79 Eocene frac well (spud late Nov 2026): A successful well could validate the 206 Bcf resource case and re-rate the equity.
  • C-78 Oligocene gas: Gas was shown on test in January 2026, giving a potential monetisation pathway.
  • Renewed Cambay sale or partnership: The company has referenced other interested parties since the Selan deal failed. The US$14m price benchmark compares with a market cap of about US$2–3m.
  • Cambay CCS pilot: A first-of-a-kind Gujarat CO2 storage hub on the 1 km-thick Olpad Formation.
  • Additional E&P opportunities: The new mandate since 16 June 2026 to assess further E&P assets.
  • Indian policy support for domestic production in an import-dependent market.

Threats

  • Funding gap and dilution: The US$0.7m loan is repayable within 12 months of drawdown. Options issued with it convert at a 10% premium.
  • Counterparty risk with Selan: Selan failed to complete the purchase because of its own shareholder's refusal (Oaktree via Blackbuck), yet it remains operator and funder of the work programme.
  • Technical risk in tight reservoirs: C-77H, a multi-stage fracked horizontal well, produced only 39 Mcf/d in April 2026.
  • Impairment risk in FY2026: Book net assets of about A$18m rested partly on the US$14m sale price, which no longer exists.
  • Residual UK liabilities: Relinquishment of a licence with legacy wells may carry regulatory obligations. The extent was not disclosed.
  • AIM listing sustainability: Shareholders voted to remain listed in December 2025, but listing costs remain heavy for a company of this size.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
4 Apr 2025Cambay PSC updateOperational
2 Jun 2025Cambay PSC updateOperational
10 Jun 2025Change of Nominated Adviser (to SP Angel)Adviser change ahead of the transaction
24 Jun 2025TR-1 major holdings notificationRegister movement
4 Jul 2025Heads of Terms: sale of remaining 50% Cambay to Selan for up to US$14mTransformational exit plan
8 Jul 2025Correction to sale announcement; Cambay work programme updateClarifications
21 Jul 2025TR-1 major holdings notificationRegister movement
4 Aug 2025US$0.5m initial payment received from Selan; C-64 sucker-rod-pump workover delayed by monsoonCash in; operational delays
27 Aug 2025Cambay PSC updateOperational
16 Sep 2025Cambay PSC updateOperational
7 Oct 2025FY2025 Annual Report: net profit A$5.0m; cash A$1.21m; net assets A$18.95m; no borrowings; going-concern uncertaintyResults
20 Oct 2025Cambay PSC update (workovers of C-64/C-74 in October)Production restoration
29 Oct 2025Selan informs Synergia of planned Cambay activityWork programme
3 Nov 2025AGM noticeGovernance
4 / 10 / 17 Nov 2025Series of Cambay PSC updates (C-78 drilling progress)Drilling
Nov 2025Camelot legacy well integrity risk assessment submitted to NSTACCS regulatory step
1 Dec 2025SPA signed with Selan; AGM results; GM convened on sale and AIM cancellationTransaction milestone
3 Dec 2025Cambay sale FAQs publishedShareholder communication
29 Dec 2025GM: sale approved; shareholders vote to remain on AIMListing retained
22 Jan 2026C-78 perforated (5 m, Oligocene OS-II); gas shown during clean-up; C-64/C-74 stabilised at about 40 bopd grossDiscovery test; low oil rates
9 Feb 2026Selan fails to satisfy SPA conditions by the 8 Feb exclusivity deadline; Synergia to examine optionsExit collapses
6 Mar 2026Production update (and correction): oil from worked-over wells rises to about 195 bopd in early MarchProduction improvement
26 Mar 2026Interim report H1 FY2026: revenue A$0.116m; loss A$0.575m; cash A$0.81m; net assets A$17.96m; going-concern uncertaintyResults
7 Apr 2026Up to US$0.7m unsecured loan from Republic (7.5% interest; options at a 10% premium)Related-party funding
5 May 2026April oil production 148 bopd, gas 39 Mcf/d; Mark Bolton steps downOps and board
12 May 2026Stacey Britza appointed NEDBoard
27 May 2026Cambay update: legacy well workover programme (C-08)Production
9 Jun 2026NSTA workshop reviews Camelot well integrity reportRegulatory
16 Jun 2026Relinquishment of Camelot CS019 announced; C-08 stabilised at about 30 bopd; strategic refocus on Cambay plus E&PStrategic pivot
1 Oct 2026C-79 design agreed: Eocene target near C-19z, fracked, DEEP rig; spud late Nov 2026 (est.)Key catalyst
9 Oct 2026Shares reported up about 10% on the day (Kalkine market note)Trading

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

2 charts
Revenue by Segment: India oil and gas sales rose from AUD 0.1 Mn in FY2022 to AUD 0.3 Mn in FY2025.
Synergia Energy Ltd — Revenue by Segment
Series (AUD Mn)FY2022FY2023FY2024FY2025
India oil and gas sales0.11.30.60.3
India % of total revenue100100100100

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.